Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening
Launched by SKANE UNIVERSITY HOSPITAL · May 25, 2007
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women aged 32-38 years old
- • Attending the Swedish population-based organised cervical screening program
- Exclusion Criteria:
- • Not providing informed consent
About Skane University Hospital
Skåne University Hospital is a leading academic medical center located in Sweden, renowned for its commitment to advancing healthcare through innovative clinical research and trials. As a key player in the Nordic healthcare landscape, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, aiming to improve patient outcomes and foster advancements in medical knowledge. With a multidisciplinary approach, Skåne University Hospital collaborates with various stakeholders, including universities and research institutions, to conduct high-quality clinical trials that address critical health challenges and contribute to the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malmo, , Sweden
Patients applied
Trial Officials
Joakim Dillner, MD
Principal Investigator
Malmo University Hospital, Lund University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials